undamentalytics Newsletter

Ahmed Nabeel: insider trades

Chief financial officer, Officer at Outset Medical, Inc. 1 open-market purchase and 13 sales not made under a pre-set plan, reported from August 11, 2021 to May 16, 2025.

Would copying Ahmed Nabeel’s purchases have beaten the S&P 500?

Too few purchases to judge. Only 1 purchase has 12 months of prices after the report; we judge insiders once they have 20. The figures below can swing a long way on a handful of trades. Buying each purchase the day after it was reported, an equal amount each, and holding it 12 months or until they reported a sale would have turned $10,000 on August 12, 2021 into $12,376 by November 2, 2026, +4.2% a year. The copy held shares only 11% of the time, so the fair comparison is the S&P 500 on those same days with Treasury bills otherwise: $11,500, +2.7% a year (the S&P 500 held throughout made $18,229, +12.2% a year). Beta against the index was 0.10. Twelve months after each report, the average purchase was −41.4% against the S&P 500 (median −41.4%), and 0% beat it. Measured from the trade date, the insider’s own timing, the average was −40.0%. After their sales, the shares moved −83.0% against the index over 12 months on average (a negative figure means selling was the right call); 100% trailed it.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

$0$10.0k$20.0k 202120222023202420252026 $18.2k$12.4k$11.5k
Copying Ahmed NabeelS&P 500, same days investedS&P 500, held throughout $10,000 copying Ahmed Nabeel’s open-market purchases from August 12, 2021, before costs and taxes, marked weekly. Each purchase gets the same starting stake, bought at the close of the first trading day after the report and sold 12 months later or the day after a reported sale of that stock; uninvested money earns the Treasury bill rate. “Same days invested” holds the S&P 500 only on the days the copy held shares, Treasury bills otherwise.
Return a year, copying
+4.2%
S&P 500, same days invested
+2.7% (held throughout +12.2%)
Time in shares
11%
Sharpe ratio (S&P 500)
0.11 (0.54)
Biggest drop (S&P 500)
−42% (−25%)
Market sensitivity (beta)
0.10
Purchases copied
1

Trade by trade

Ahmed Nabeel: trades against the S&P 500 afterwards
MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 1 +33.2% +33.2% 100% 1 — — Not enough years
Purchases, 6 months after the report 1 −1.5% −1.5% 0% 1 — — Not enough years
Purchases, 12 months after the report 1 −41.4% −41.4% 0% 1 — — Not enough years
Purchases, 12 months after the trade 1 −40.0% −40.0% 0% 1 — — Not enough years
Sales, 3 months after the report 9 −37.8% −36.2% 100% 4 −5.43 0.012 Some evidence: seller right
Sales, 12 months after the report 9 −83.0% −106.2% 100% 4 −4.22 0.024 Some evidence: seller right
Sales, 12 months after the trade 9 −83.0% −107.6% 100% 4 −4.15 0.025 Some evidence: seller right

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
Outset Medical, Inc. OM Chief Financial Officer113August 11, 2021May 16, 2025

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
May 16, 2025May 15, 2025 OM Sale $10,401 −39.7%−103.7%−107.5%
January 22, 2025January 21, 2025 OM Sale $27,430 not yetnot yetnot yet
January 13, 2025January 13, 2025 OM Sale $23,515 not yetnot yetnot yet
May 17, 2024May 16, 2024 OM Sale $13,831 not yetnot yetnot yet
February 16, 2024February 15, 2024 OM Sale $15,719 not yetnot yetnot yet
January 8, 2024January 8, 2024 OM Sale $58,792 −63.9%−106.2%−107.6%
August 17, 2023August 16, 2023 OM Sale $23,632 −68.1%−125.6%−123.4%
May 16, 2023May 16, 2023 OM Sale $30,502 −36.2%−111.4%−113.3%
February 16, 2023February 16, 2023 OM Sale $37,980 −20.1%−111.4%−109.9%
January 30, 2023January 27, 2023 OM Sale $137,869 −32.7%−111.6%−111.4%
August 9, 2022August 8, 2022 OM Sale $20,174 −36.0%−30.4%−30.2%
July 19, 2022July 19, 2022 OM Sale $13,033 −6.4%−3.7%−0.6%
March 11, 2022March 9, 2022 OM Sale $19,900 −37.3%−43.3%−43.6%
August 11, 2021August 10, 2021 OM Purchase $37,134 +33.2%−41.4%−40.0%

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Ahmed Nabeel traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.